Source Link: https://covid19criticalcare.com/wp-content/uploads/2022/03/Statement-on-Together-Trial-WSJ-Article-Mar-18-1.pdf
This article combines a government study with the FLCCC response. This was yet another special interest funded study to disprove efficacy of Ivermectin, despite numerous other studies proving otherwise.
FLCCC Response
Statement-on-Together-Trial-WSJ-Article-Mar-18-1Study
Effect of Early Treatment with Ivermectin among Patients with Covid-19
nejmoa2115869